Literature DB >> 3487916

Substances that rapidly augment ionic conductance of endothelium in cerebral venules.

S P Olesen, C Crone.   

Abstract

Classical techniques for studying modulations of microvascular permeability have a time resolution of minutes. A newly developed method allows continuous measurement of the electrical resistance of the microvascular membrane in vivo (Olesen & Crone 1983). The technique exploits microelectrodes impaled into the vascular lumen and is based on cable analysis of the vessel. It was applied to venules on the surface of the frog brain to test the effect on microvascular permeability of a wide variety of substances. The following agents increased ionic permeability reversibly within seconds: 5-hydroxytryptamine, bradykinin, ATP, ADP, AMP, phospholipase A2, arachidonic acid, leukotriene C4, oxygen-derived free radicals, ionophore A23187, and unbound Evans blue dye. An irreversible permeability increase was induced by protamine sulphate, neuraminidase, trypsin, melittin, and snake venoms from Crotalus durissus terrificus and Bothrops atrox. The following substances were without effect within an administration period of 5 min: histamine, epinephrine, putrescine, angiotensin II, vasoactive intestinal polypeptide (VIP), substance P, neurotensin, vasopressin, adenosine, PGE2, PGF2 alpha, prostacyclin (PGI2), leukotriene B4, albumin, heparin, plant cytokinins, hyaluronidase, thrombin, wasp venom. Variations in pH between 5.1 and 8.6 did not change permeability. Three conclusions are drawn from the observations: (1) the permeability of cerebral microvessels can be modulated by specific agents, (2) the agents induced changes in the endothelium within a few seconds, and (3) the rapid permeability increase induced by inflammatory mediators was less than two-fold and reversible within minutes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487916     DOI: 10.1111/j.1748-1716.1986.tb07898.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  18 in total

1.  Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat.

Authors:  M H Sarker; D E Hu; P A Fraser
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

Review 2.  The adult respiratory distress syndrome.

Authors:  N F Voelkel
Journal:  Klin Wochenschr       Date:  1989-06-01

3.  Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium.

Authors:  H J Schnittler; A Wilke; T Gress; N Suttorp; D Drenckhahn
Journal:  J Physiol       Date:  1990-12       Impact factor: 5.182

4.  Alterations in transendothelial electrical resistance by vasoactive agonists and cyclic AMP in a blood-brain barrier model system.

Authors:  R D Hurst; J B Clark
Journal:  Neurochem Res       Date:  1998-02       Impact factor: 3.996

5.  Two components of blood-brain barrier disruption in the rat.

Authors:  A S Easton; M H Sarker; P A Fraser
Journal:  J Physiol       Date:  1997-09-15       Impact factor: 5.182

6.  Knockdown of circulating C1 inhibitor induces neurovascular impairment, glial cell activation, neuroinflammation, and behavioral deficits.

Authors:  Dorit Farfara; Emily Feierman; Allison Richards; Alexey S Revenko; Robert A MacLeod; Erin H Norris; Sidney Strickland
Journal:  Glia       Date:  2019-03-18       Impact factor: 7.452

7.  The contribution of arachidonic acid to the aetiology and pathophysiology of focal brain oedema; studies using an infusion oedema model.

Authors:  I R Whittle; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

Review 8.  P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

Authors:  Gary A Weisman; Lucas T Woods; Laurie Erb; Cheikh I Seye
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

9.  Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain.

Authors:  Mansi Krishan; Gary A Gudelsky; Pankaj B Desai; Mary Beth Genter
Journal:  Drug Deliv       Date:  2013-10-14       Impact factor: 6.419

10.  RMP-7 : Potential as an Adjuvant to the Drug Treatment of Brain Tumours.

Authors:  A V Boddy; H D Thomas
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.